Audentes Therapeutics, Inc. Operating Expenses
Audentes Therapeutics, Inc. reported Operating Expenses of $47.83 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-11-07
- Audentes Therapeutics, Inc. operating expenses for the quarter ending 2019-09-30 was $47.83M, a 26.74% increase year-over-year.
- Audentes Therapeutics, Inc. operating expenses for the quarter ending 2019-06-30 was $47.08M, a 44.28% increase year-over-year.
- Audentes Therapeutics, Inc. operating expenses for the quarter ending 2019-03-31 was $51.83M, a 96.25% increase year-over-year.
- Audentes Therapeutics, Inc. operating expenses for the quarter ending 2018-12-31 was $37.60M, a 39.87% increase year-over-year.
- Audentes Therapeutics, Inc. operating expenses for fiscal 2018 was $134.37M, a 44.21% increase from fiscal 2017.
- Audentes Therapeutics, Inc. operating expenses for fiscal 2017 was $93.18M, a 55.18% increase from fiscal 2016.
- Audentes Therapeutics, Inc. operating expenses for fiscal 2016 was $60.05M, a 124.67% increase from fiscal 2015.
- Audentes Therapeutics, Inc. operating expenses for fiscal 2015 was $26.73M, a 144.07% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | $47.83M 10-Q · filed 2019-11-07 | $94.90M derived: sum of 2 quarters · filed 2019-11-07 | $146.73M 10-Q · filed 2019-11-07 | $184.33M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-06-30 | $47.08M 10-Q · filed 2019-08-07 | $98.91M 10-Q · filed 2019-08-07 | $136.50M derived: sum of 3 quarters · filed 2019-08-07 | $174.24M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-03-31 | $51.83M 10-Q · filed 2019-05-08 | $89.43M derived: sum of 2 quarters · filed 2019-05-08 | $127.16M derived: sum of 3 quarters · filed 2019-11-07 | $159.79M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-12-31 | $37.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $75.33M derived: sum of 2 quarters · filed 2019-11-07 | $107.96M derived: sum of 3 quarters · filed 2019-11-07 | $134.37M 10-K · filed 2019-03-01 | |
| 2018-09-30 | $37.73M 10-Q · filed 2019-11-07 | $70.36M derived: sum of 2 quarters · filed 2019-11-07 | $96.77M 10-Q · filed 2019-11-07 | $123.66M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $32.63M 10-Q · filed 2019-08-07 | $59.04M 10-Q · filed 2019-08-07 | $85.92M derived: sum of 3 quarters · filed 2019-08-07 | $111.13M derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | $26.41M 10-Q · filed 2019-05-08 | $53.29M derived: sum of 2 quarters · filed 2019-05-08 | $78.50M derived: sum of 3 quarters · filed 2019-05-08 | $101.34M derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $26.88M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $52.09M derived: sum of 2 quarters · filed 2019-03-01 | $74.93M derived: sum of 3 quarters · filed 2019-03-01 | $93.18M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $25.21M 10-Q · filed 2018-11-07 | $48.05M derived: sum of 2 quarters · filed 2018-11-07 | $66.30M 10-Q · filed 2018-11-07 | $86.13M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $22.84M 10-Q · filed 2018-08-07 | $41.09M 10-Q · filed 2018-08-07 | $60.92M derived: sum of 3 quarters · filed 2019-03-01 | $76.39M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $18.25M 10-Q · filed 2018-05-10 | $38.08M derived: sum of 2 quarters · filed 2019-03-01 | $53.55M derived: sum of 3 quarters · filed 2019-03-01 | $67.75M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $19.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $35.30M derived: sum of 2 quarters · filed 2019-03-01 | $49.51M derived: sum of 3 quarters · filed 2019-03-01 | $60.05M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $15.47M 10-Q · filed 2017-11-14 | $29.68M derived: sum of 2 quarters · filed 2017-11-14 | $40.21M 10-Q · filed 2017-11-14 | $50.25M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-06-30 | $14.20M 10-Q · filed 2017-08-10 | $14.20M 10-Q · filed 2016-09-01 | $24.74M 10-Q · filed 2017-08-10 | $34.77M derived: sum of 3 quarters · filed 2018-03-09 | $41.77M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $10.54M 10-Q · filed 2017-05-11 | $20.57M derived: sum of 2 quarters · filed 2018-03-09 | $27.57M derived: sum of 3 quarters · filed 2018-03-09 | $33.10M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2015-12-31 | $10.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $17.03M derived: sum of 2 quarters · filed 2018-03-09 | $22.56M derived: sum of 3 quarters · filed 2018-03-09 | $26.73M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $7.00M 10-Q · filed 2016-11-10 | $12.53M derived: sum of 2 quarters · filed 2016-11-10 | $16.69M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $5.53M 10-Q · filed 2016-09-01 | $9.70M 10-Q · filed 2016-09-01 | |||
| 2014-12-31 | $10.95M 10-K · filed 2017-03-13 |